Raleigh Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $94.2K | Sell |
|
|||||
|
2025
Q2 | $128K | Sell |
|
|||||
|
2025
Q1 | $1.98M | Sell |
|
|||||
|
2024
Q4 | $2.23M | Sell |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q2 | $1.24M | Buy |
|
|||||
|
2024
Q1 | $1.43M | Buy |
|
|||||
|
2023
Q4 | $203K | Buy |
|
|||||
|
2023
Q3 | $80.5K | Sell |
|
|||||
|
2023
Q2 | $769K | Buy |
|
|||||
|
2023
Q1 | $826K | Buy |
|
|||||
|
2022
Q4 | $747K | Sell |
|
|||||
|
2022
Q3 | $1.39M | Sell |
|
|||||
|
2022
Q2 | $1.66M | Sell |
|
|||||
|
2022
Q1 | $1.6M | Buy |
|
|||||
|
2021
Q4 | $7K | Buy |
|